Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CHIP-seq for TCF21 overexpressing tumor pericytes

ABSTRACT: CHIP-seq for TCF21 overexpressing tumor pericytes

PROVIDER: PRJNA822811 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18590260_1.fastq.gz	Fastqsanger.gz
	SRR18590260_2.fastq.gz	Fastqsanger.gz
	SRR18590261_1.fastq.gz	Fastqsanger.gz
	SRR18590261_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

RNA-seq for TCF21 overexpressing tumor pericytes

Project description:RNA-seq for TCF21 overexpressing tumor pericytes

| PRJNA822812 | ENA

RNA-seq and CHIP-seq for TCF21 overexpressing tumor pericytes

Project description:RNA-seq and CHIP-seq for TCF21 overexpressing tumor pericytes

| PRJNA824140 | ENA

RNA-seq and CHIP-seq for TCF21 overexpressing tumor pericytes

Project description:RNA-seq and CHIP-seq for TCF21 overexpressing tumor pericytes

| PRJNA822808 | ENA

CHIP-seq for NKX2-3 overexpressing tumor pericytes

Project description:CHIP-seq for NKX2-3 overexpressing tumor pericytes

| PRJNA1044133 | ENA

CHIP-seq for TCF21 overexpressing tumor pericytes

Project description:This study aims to investigate genes regulated by TCF21.

2022-04-06 | GSE200063 | GEO

RNA-seq for TCF21 overexpressing tumor pericytes

Project description:This study aims to investigate genes regulated by TCF21

2022-04-06 | GSE200064 | GEO

Proteomic data for tumor pericytes with TCFA2 overexpression

Project description:This study aims to investigate differentially expressed proteins in tumor pericytes with or without TCAF2-ovexpression. Tumor pericytes were isolated from tumor of patients with colorectal cancer. Then, tumor pericytes were cultured, transfected with vector or TCAF2 overexpressing plasmid. Top ten cytokines were screened and Wnt5a was the most significant one.

2024-01-26 | PXD032935 | Pride

Proteomic data for tumor pericytes derived from colorectal cancer patients

Project description:This study aims to investigate differentially expressed proteins in tumor pericytes derived from colorectal cancer patients with or without liver metastasis. Tumor pericytes were isolated from tumor of colorectal cancer patients with or without liver metastasis. Then, tumor pericytes were cultured and subjected to proteomic analysis. TCAF2 was significantly increased in tumor pericytes from liver metastasis patients.

2024-01-26 | PXD033011 | Pride

Identification of new TCF21 targets in adrenocortical carcinoma cells

Project description:Transcription factor 21 (TCF21) directly binds and regulates SF1 in tumor and normal adrenocortical cells, and both are involved in the development and steroidogenesis of the adrenal cortex. TCF21 is a tumor suppressor gene and its expression is reduced in malignant tumors. In adrenocortical tumors, it is less expressed in adrenocortical carcinomas (ACC) than in adrenocortical adenomas (ACA) and normal tissue. However, a comprehensive analysis to identify TCF21 targets have not yet been conducted in any type of cancer. In this study, we performed Chromatin Immunoprecipitation and Sequencing (ChIP-Seq) in adrenocortical carcinoma cell line (NCI-H295R) overexpressing TCF21, with the aim of identifying TCF21 new targets. The five most frequently identified sequences corresponded to the PRDM7, CNTNAP2, CACNA1B, PTPRN2 and KCNE1B genes. Validation experiments showed that, in NCI-H295R cells, TCF21 regulates gene expression positively in PRDM7 and negatively in CACNA1B. Recently, it was observed that the N-type calcium channel v2.2 (Cav2.2) encoded by CACNA1B gene is important in Angiotensin II signal transduction for corticosteroid biosynthesis in NCI-H295R adrenocortical carcinoma cells. Indeed, TCF21 inhibits CACNA1B and Cav2.2 expression in NCI-H295R. In addition, in a cohort of 55 adult patients with adrenocortical tumor, CACNA1B expression was higher in ACC than ACA, and was related to poor disease-free survival in ACC patients. These results suggest a mechanism of steroidogenesis control by TCF21 in adrenocortical tumor cells, in addition to the control observed through SF1 inhibition. Importantly, steroid production could impair tumor immunogenicity, contributing to the immune resistance described in adrenal cancer.

2022-06-30 | GSE179308 | GEO

RNA-seq and CHIP-seq for TCF21 overexpressing tumor pericytes

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-04-06 | GSE200065 | GEO